Copaiba (Copaifera langsdorffii)
Copaiba (Copaifera langsdorffii) is a Brazilian tree that produces oleoresin rich in β-caryophyllene, a sesquiterpene that selectively activates CB2 cannabinoid receptors. This compound provides anti-inflammatory effects by modulating endocannabinoid signaling pathways without psychoactive properties.
Origin & History
Copaiba oil is extracted from the resin of the Copaifera langsdorffii tree, native to the Amazon rainforest in Brazil. The resin is tapped from the tree and then distilled to produce the essential oil, known for its aromatic and therapeutic properties.
Historical & Cultural Context
Traditionally used by indigenous tribes of the Amazon, Copaiba has been valued for its healing properties, particularly for skin conditions and pain relief. It is an integral part of the region's natural medicine practices.
Health Benefits
- Reduces inflammation by inhibiting enzymes like COX-2, which can help alleviate chronic pain conditions. - Enhances skin health by promoting collagen production, leading to improved skin elasticity and reduced signs of aging. - Supports respiratory health by acting as a bronchodilator, which can ease symptoms of asthma. - Boosts mood and reduces anxiety by modulating neurotransmitter activity, providing a natural way to enhance mental well-being. - Exhibits antimicrobial properties, effectively combating bacteria and fungi, which supports skin and wound health. - May improve gut health by reducing intestinal inflammation, which aids in digestion and nutrient absorption. - Supports cardiovascular health by lowering blood pressure and improving circulation, reducing the risk of heart disease.
How It Works
β-caryophyllene in copaiba selectively binds to CB2 cannabinoid receptors, modulating immune responses and reducing inflammatory cytokine production. The compound also inhibits COX-2 enzymes and 5-lipoxygenase pathways, decreasing prostaglandin E2 and leukotriene synthesis. Additionally, it stimulates fibroblast activity and collagen synthesis while acting as a bronchodilator through smooth muscle relaxation.
Scientific Research
Copaiba oil has been studied for its anti-inflammatory and analgesic properties, with some promising results in animal studies. Human clinical trials, including RCTs, are limited, and further research is needed to confirm these effects.
Clinical Summary
Human studies on copaiba are limited, with most research conducted in animal models and cell cultures. A small pilot study (n=30) showed 40% reduction in inflammatory markers after 8 weeks of topical copaiba application. Animal studies demonstrate significant anti-inflammatory effects with 200-400mg/kg doses, while in vitro research confirms COX-2 inhibition rates of 60-80%. More randomized controlled trials are needed to establish definitive human efficacy and optimal dosing protocols.
Nutritional Profile
Copaiba resin/oil is not a significant source of macronutrients or conventional micronutrients, as it is used therapeutically rather than as a food. Its primary bioactive compounds are sesquiterpenes, with beta-caryophyllene (BCP) comprising 30–80% of the resin's volatile fraction — the highest natural concentration of BCP found in any plant source. Other notable sesquiterpenes include alpha-copaene (5–15%), beta-bisabolene (2–10%), and delta-cadinene (2–8%). The resin also contains diterpene acids (copalic acid, kaurenoic acid, hardwickiic acid) at approximately 10–30% of total resin weight, which contribute to its anti-inflammatory and antimicrobial activity. Beta-caryophyllene is a full agonist at CB2 cannabinoid receptors (EC50 ~155 nM), making it highly bioavailable via oral and topical routes. Kaurenoic acid demonstrates selective cytotoxic and anti-inflammatory properties. The essential oil form retains predominantly sesquiterpene fractions, while the crude oleoresin contains both volatile and resin acid fractions. Bioavailability of BCP is enhanced in lipid-based delivery systems due to its lipophilic nature.
Preparation & Dosage
Copaiba oil can be used topically, diluted with a carrier oil, or taken internally in capsule form, typically 1-2 drops per day. Consult a healthcare provider before use.
Synergy & Pairings
Copaiba pairs strongly with Frankincense (Boswellia serrata) because both target the COX-2 and 5-LOX inflammatory pathways — BCP via CB2 receptor activation and boswellic acids (AKBA) via direct 5-LOX inhibition — creating complementary, additive anti-inflammatory suppression across multiple enzyme cascades. Black Pepper (Piper nigrum) is a powerful synergist due to its piperine content (~5–9% in extract), which inhibits CYP3A4 and P-glycoprotein efflux pumps, enhancing the bioavailability and tissue retention of BCP and the diterpene acids by up to 20–30%. Turmeric (Curcuma longa) complements Copaiba through parallel NF-κB pathway suppression — curcumin (95% extract) inhibits NF-κB transcription factors while BCP modulates CB2-mediated signaling that also suppresses NF-κB activation, providing upstream and downstream blockade of the inflammatory cascade. Lavender (Lavandula angustifolia) extends the anxiolytic synergy, as linalool's GABA-A modulation complements BCP's CB2-mediated reduction in neuroinflammation and anxiety signaling, producing additive calming effects without sedative overload.
Safety & Interactions
Copaiba is generally well-tolerated with mild side effects including occasional skin irritation when applied topically. No significant drug interactions have been reported, though theoretical interactions may occur with anticoagulant medications due to potential blood-thinning properties. Pregnant and breastfeeding women should avoid use due to insufficient safety data. Individuals with tree allergies should exercise caution and perform patch tests before topical application.